bioAffinity Technologies announces about $4 million share financing

bioAffinity Technologies said it entered a definitive agreement for a registered direct offering and concurrent private placement expected to raise about $4 million before fees and expenses. The company said it plans to use the net proceeds for working capital, CyPath Lung sales support and general corporate purposes.